Global Small Molecule CDMO Benchmarking Report 2022: Analysis of the Current Outsourcing Trends and Practices

DUBLIN, June 3, 2022 – The “Small Molecule Drug Product CDMO Benchmarking (5th Ed.)” report has been added to’s offering.

The Small Molecule Drug Product Contract Manufacturing Quality Benchmarking report brings with it a wealth of knowledge and information created with two goals in mind: to help biopharmaceutical companies make more informed CMO decisions and to help CMOs optimize operational and marketing strategies.

This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality across a series of 23 performance attributes specific to outsourced drug product manufacturing.

In this Consumer Reports-style analysis, the publisher presents data on 487 service encounters from 139 respondents who have been involved in outsourced drug product projects in the past 18 months.

Drug developers:

Make a more educated purchase of CMO services by understanding which manufacturers best fit your company’s needs in addition to how individual CMOs have measured up to sponsor-peer expectations on similar projectsUncover which CMO attributes drive outsourcing partner selection for drug product manufacturing as well as which CMO attributes have gained importance over the past 12 months among industry peersGain insight into CMO customer loyalty, an index based on customer satisfaction, willingness to recommend, and likelihood to use again, along with verbatim responses from customers regarding their experience

Contract Manufacturers:

Understand your company’s competitive positioning as well as delivery strengths and weaknesses and use this information to develop targeted messaging on true areas of strengthCompare your company’s performance against its competitors across 23 performance metrics specific to outsourced drug product manufacturing and related servicesGain insight into drug developers’ outsourcing preferences and practices with respect to CMO selection and CMO preference for outsourced small molecule drug product manufacturing

Major Topics:

Outsourcing Philosophies and PracticesCMO Selection DriversCMO Perceptions and InteractionsCMO Performance and LoyaltySmall Molecule Drug Product CMO Competitive LandscapeCompany Service Quality ProfilesStudy Data

CMO Performance and Loyalty
Primary Section TakeawaysA Note on Performance CalculationsPerformance Across ProvidersDelivery FactorsOrganization FactorsCapabilitiesStaff CharacteristicsService CapabilitiesCMO Performance: Delivery FactorsCMO Performance: Organization FactorsCMO Performance: Capabilities RatingsCMO Performance: Staff CharacteristicsCMO Performance: Service CapabilitiesCMO LoyaltyCMO Loyalty: 3-Year Rolling Average.

The authored article is shared with Prittle Prattle News

Must Read- Vinod Cookware
Follow Us: Facebook Instagram | Twitt
Skip to toolbar